Home /
Portugal rejects innovative Alzheimer's drugs Infarmed issues a negative opinion on the reimbursement of new Alzheimer 's drugs.
Published 8sem · 1 source Notable · updated 1sem
The fact These treatments, already approved in Europe , do not provide added therapeutic value.
The Minister of Health confirms this controversial decision.
🔗 Click the link to read an article on the topic:
Why it matters Ce rejet soulève des questions sur l'accès aux traitements innovants en Europe et les critères d'évaluation des médicaments, avec des conséquences pour les patients atteints d'Alzheimer au Portugal.
What if you saw the whole news differently? Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page. → Portugal · © OpenStreetMap, OpenMapTiles, OpenFreeMap World map → Auto-synthesis from 1 media source · identified on July 21, 2026